Cardiovascular outcomes in Long Covid: A systematic review and meta-analysis

Introduction

This research paper presents a study on Long Covid and its association with cardiovascular complications. The systematic review and meta-analysis are based on a collection of articles that examine various vascular and heart diseases, including stroke, arrhythmia, coronary disease, hypertension, and others. The findings indicate a higher prevalence of these cardiovascular complications in patients with Long Covid, defined as symptoms persisting for at least two months. Greater attention should be given to the care of Long Covid patients who may be at risk for cardiovascular issues.

Summary and Conclusion

Long Covid may persist in individuals who have initially recovered from the infection, even several months after the acute illness. The cardiovascular system, along with the lungs, can be affected by long-term complications, and the incidence of such cases is rising globally.

A substantial number of studies have been conducted on this topic; however, due to their heterogeneity, drawing clear conclusions remained challenging. To address this, a systematic review and meta-analysis was undertaken, initially identifying 11,640 relevant records. After applying refined eligibility criteria, only eight studies were included in this comprehensive analysis.

The study identified the primary cardiovascular complications associated with Long Covid, including thromboembolic disorders, coronary disease, stroke, arrhythmia, cardiomyopathy (including myocarditis), hypertension, heart failure, and cardiogenic shock. The findings revealed an increased risk of new-onset cardiovascular diseases in Long Covid patients compared to a non-covid control group. Notably, all the aforementioned conditions showed a higher prevalence in Long Covid patients, with hypertension, stroke, and thromboembolic disease occurring at nearly two to three times the rate observed in the non-Covid population.

Some studies suggested that the mechanisms underlying the development of cardiovascular disease during the Long Covid period remain uncertain. However, there is evidence of vascular dysfunction and inflammation in COVID-19 patients. These factors may contribute to blood coagulation and micro-thrombosis, leading to various cardiovascular complications.

According to some authors, the mechanism of cardiovascular complications in Long Covid may be similar to that of Long Covid itself – endothelial cell infection followed by cell death. In patients with high cardiovascular risk, this process can result in cardiac fibrosis and scar formation in affected organs, ultimately leading to the aforementioned cardiovascular conditions.

Given the increasing number of COVID-19 cases, these findings highlight the need for a greater allocation of medical resources to support COVID-19 survivors. The authors emphasize the following key recommendations:

• Gaining a better understanding of the mechanisms behind Long Covid, particularly its cardiovascular complications.
• Focusing on the treatment of cardiovascular diseases in patients recovering from COVID-19 while exercising caution with anticoagulant use (blood thinners which are recommended during COVID-19).
• Ensuring stable cardiac function during COVID-19 and Long Covid by regularly monitoring electrocardiograms and relevant biomarkers, especially in high-risk patients.

Paper available here.

Summary by Nikky Yusifova